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Background-—Fetal exposure to preeclampsia is associated with higher blood pressure and later risk of stroke. We aimed to
investigate the associations of maternal preeclampsia, gestational hypertension, and maternal blood pressure change in pregnancy
with offspring cardiac structure and function in adolescence.
Methods and Results-—Using data from a prospective birth cohort study, we included offspring who underwent echocardiography
(mean age, 17.7 years; SD, 0.3; N=1592). We examined whether hypertensive disorders of pregnancy were associated with
offspring cardiac structure and systolic/diastolic function using linear regression. Using multilevel linear spline models
(measurement occasions within women), we also investigated whether rate of maternal systolic/diastolic blood pressure change
during pregnancy (weeks 8–18, 18–30, 30–36, and 36 or more) were associated with offspring outcomes. Main models were
typically adjusted for maternal age, offspring age and sex, prepregnancy body mass index, parity, glycosuria/diabetes mellitus,
education, and maternal smoking. Exposure to maternal preeclampsia (0.025; 95% CI, 0.008–0.043) and gestational hypertension
(0.010; 0.002–0.017) were associated with greater relative wall thickness. Furthermore, preeclampsia was also associated with a
smaller left ventricular end-diastolic volume (9.0 mL; 15 to 3.1). No associations were found between hypertensive disorders
of pregnancy and offspring cardiac function. Positive rate of maternal systolic blood pressure change during weeks 8 to 18 was
associated with greater offspring left ventricular end-diastolic volume, left ventricular mass indexed to height2.7, and E/A.
Conclusions-—Adolescent offspring exposed to maternal preeclampsia had greater relative wall thickness and reduced left
ventricular end-diastolic volume, which could be early signs of concentric remodeling and affect future cardiac function as well as
risk of cardiovascular disease. ( J Am Heart Assoc. 2016;5:e003906 doi: 10.1161/JAHA.116.003906)
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P reeclampsia is diagnosed in 2% to 5% of pregnancies,with the incidence for other forms of hypertension in
pregnancy being about twice as high.1 Whereas “gestational
hypertension” describes new hypertension that manifests in
previously normotensive women following the 20th week of
pregnancy, in preeclampsia the hypertension is typically
complicated by concomitant proteinuria. A complex syndrome
of suboptimal placentation, increased levels of antiangiogenic
factors, and fetal hypoxia, preeclampsia is associated with
signiﬁcant mortality and morbidity in mothers and off-
spring.2,3 No deﬁnite cure other than delivery is known.4
Offspring exposed to maternal preeclampsia have higher
blood pressure and body mass index (BMI) during childhood
and early adolescence.5,6 Exposure to maternal preeclampsia
has also been reported to be associated with a greater risk of
stroke in adulthood.7 Thus, the worse cardiovascular disease
(CVD) risk proﬁle observed in exposed offspring in adoles-
cence might translate into CVD events later in life. To
facilitate risk stratiﬁcation and preventive efforts, it is
important to identify potential CVD risk factors and pathways
to disease. Noticeably, both preeclampsia and gestational
hypertension are associated with greater long-term CVD risk
in exposed mothers.8,9 Shared genetic risk between the
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mother and offspring may thus be a contributor of increased
offspring risk. However, offspring exposed to maternal
preeclampsia have decreased ﬂow-mediated dilation, which
was not observed in their unexposed siblings, suggesting a
direct intrauterine effect.10 Furthermore, a direct inﬂuence of
exposure to preeclampsia on fetal cardiac development is
plausible,11 given that altered pressure loads and hypoxia
during development of the myocardium might have a long-
lasting effect on its structure and function.12,13 The increase
in number of myocytes in the human myocardium
plateaus during early life, and subsequent cardiac growth is
mostly mediated through hypertrophy of previously formed
myocytes.14
Our aim was to investigate whether maternal preeclampsia
and gestational hypertension were associated with offspring
cardiac structure and function in adolescence. As recently
demonstrated using data from the same cohort,15 patterns of
maternal blood pressure (BP) change in pregnancy are
associated with birth weight and gestational length. There-
fore, we also examined associations between rate of maternal
BP change in pregnancy and offspring cardiac outcomes. We
hypothesized that (1) cardiac outcomes would be less
favorable in offspring exposed to maternal preeclampsia and
gestational hypertension, compared to offspring of normoten-
sive mothers, and (2) adverse maternal BP change during
pregnancy would be associated with poorer offspring cardiac
structure and function.
Methods
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective, population-based birth cohort
study that recruited 14 541 pregnant women resident in the
county of Avon, United Kingdom, with expected dates of
delivery between April 1, 1991 and December 31, 1992.
There were 13 617 mother-offspring pairs from singleton live
births who survived to ≥1 year of age. Of these, 4770
offspring attended the follow-up clinic at age 17 years when a
random subsample also underwent echocardiography
(N=1964 singletons from the original cohort). The current
study sample includes all singleton offspring with complete
data on all covariables (N=1592; 81.1% of singletons who
underwent echocardiography; see Figure 1). Please note that
the study website contains details of all the data that are
available through a fully searchable data dictionary (http://
www.bris.ac.uk/alspac/researchers/data-access/data-dic-
tionary/). Ethical approval for the study was obtained from
the ALSPAC Ethics and Law Committee and the local research
ethics committee, and informed consent was obtained from
all participants. The study complies with the Declaration of
Helsinki.
Maternal Data
Data collection in the ALSPAC mothers has been previously
described in detail.16 Single brachial BP was measured in the
seated position using the appropriate cuff size at regular
antenatal care visits. All of the BP and urine dipstick
proteinuria and glycosuria measurements, which were taken
routinely as part of antenatal care, were abstracted from
obstetric medical charts by 6 trained research midwives.
There was no between-midwife variation in mean values of the
data abstracted, and error rates were consistently <1% in
repeated data entry checks. Using these data, we classiﬁed
the pregnant women into 1 of 4 mutually exclusive categories
of hypertension during pregnancy: normotensive, preeclamp-
sia, gestational hypertension, or essential hypertension. We
deﬁned gestational hypertension as hypertension manifesting
during pregnancy according to the criteria of the International
Society for the Study of Hypertension in Pregnancy17 (systolic
BP [SBP] ≥140 mm Hg or diastolic BP [DBP] ≥90 mm Hg on
at least 2 occasions after the 20th gestational week). For the
deﬁnition of preeclampsia, we used the BP limits as above but
with concomitant proteinuria, measured with a dipstick, on
both hypertensive occasions. In addition, we categorized
those exposed to maternal preeclampsia superimposed on
Figure 1. Study sample ﬂow chart. ALSPAC indicates Avon
Longitudinal Study of Parents and Children.
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essential hypertension in the preeclampsia group. Women
who reported having been diagnosed previously with hyper-
tension outside of pregnancy and were aged >16 years at
diagnosis were considered to have essential hypertension. We
included offspring born to these mothers with essential
hypertension during pregnancy as a separate exposure group
for comparison and for completeness. We also identiﬁed
women with glycosuria or diabetes mellitus based on
antenatal care records. Glycosuria was deﬁned as a record
of at least ++ (equal to 13.9 mmol/L or 250 mg/100 mL) on
at least 2 occasions at any time during the pregnancy.
Information on gestational length was also abstracted from
medical records. Information on prepregnancy weight, height,
maternal level of education, and maternal smoking during
pregnancy were collected by questionnaires during early
pregnancy. Maternal smoking was categorized as never,
stopped before the second trimester, or smoked throughout
pregnancy. Maternal level of education was categorized as
compulsory/vocational, compulsory with higher academic
achievement, secondary with academic preparation, or uni-
versity degree.
Offspring Data
During the age 17 clinic assessment, offspring brachial BP
(typically from the right arm) was measured with the subject
in a sitting position using an Omron 705-IT machine (Omron
Healthcare Ltd, Milton Keynes, UK). The mean of 2 readings,
respectively, was used in this study. Mean arterial pressure
(MAP) was calculated using SBP and DBP as
MAP=DBP+(SBPDBP)/3. Weight was measured in light
clothing to the nearest 0.1 kg by using Tanita scales (Tanita
Europe BV, Amsterdam, The Netherlands). Height was mea-
sured without shoes to the nearest 0.01 m using a Harpenden
stadiometer (Holtain Ltd, Crymych, UK). BMI was calculated
as (weight in kilograms)/(height in meters)2. Offspring birth
weight was extracted from obstetric records as described for
the mothers above.
Echocardiography examinations in offspring
All measurements were performed according to American
Society of Echocardiography guidelines. Echocardiography
was performed by 1 of 2 experienced echocardiographers
following a standard examination protocol using an HDI 5000
ultrasound machine (Phillips Healthcare, Amsterdam, The
Netherlands) equipped with a P4-2 Phased Array ultrasound
transducer. As outcomes, we focused on 3 measures of
cardiac structure (relative wall thickness, left ventricular mass
indexed to height in m2.7 [LVMI], and left ventricular end
diastolic volume), systolic function (ejection fraction [EF],
midwall fractional shortening [MFS], and left ventricular wall
velocity as measured with tissue doppler [s0]), and diastolic
function (E/A wave ratio, E/e0 wave ratio, and left atrial
diameter indexed to height in m2.7 [LADI]), respectively.
Though LADI is not a strictly functional measure, the size of
the left atrium is an indicator of left ventricular diastolic
function. Mean fractional shortening (MFS) and left atrial
diameter were measured using M-mode. Tissue Doppler
echocardiography was performed in the 4-chamber view on
the lateral left ventricular wall to obtain myocardial wall
velocities. Peak early diastolic (e0) and atrial contraction (a0)
tissue velocities were recorded with a 5-mm sample volume
over the mitral valve annulus for 8 to 10 cycles. Peak systolic
left ventricular tissue velocities (s0) was calculated as the
average from s0 measurements of the lateral and septal left
ventricular wall, both measured as above during 3 time
points each. The velocity proﬁle for transmitral ﬂow was
recorded with the patient in passive end expiration. Peak ﬂow
velocity of the early (E) and atrial (A) waves was measured
from the 3 consecutive cardiac cycles displaying the highest
measurable velocity proﬁles. EF was calculated as the percent
of the end-diastolic volume that was ejected each cardiac
cycle. Relative wall thickness was calculated using posterior
wall thickness in diastole and left ventricular internal diameter
in diastole.
Ongoing quality control was performed throughout the
study, and reproducibility of echocardiographic examinations
was assessed by recalling 30 participants and repeating their
measurements. The intraclass correlation of repeated mea-
surements ranged from 0.75 to 0.93 (intraobserver) and 0.78
to 0.93 (interobserver).
Statistical Analyses
All analyses were conducted in STATA v. 13.1 for Windows
(StataCorp LP, College Station, TX). To investigate the
association between maternal blood pressure change during
pregnancy and offspring cardiac outcomes, we used MLWin
through the “runmlwin”18 procedure and the “reffadjust”
package in STATA. Results are presented with 95% CIs.
Preeclampsia, gestational hypertension, and offspring
cardiac structure and function
We used linear regression models to study the associations
between preeclampsia and hypertension in pregnancy with
offspring cardiac outcomes. We considered the following
covariables as confounders (occurring before the diagnosis of
maternal preeclampsia): maternal age, prepregnancy BMI,
parity, glycosuria/diabetes mellitus, educational level, and
smoking during pregnancy. Potential mediators were gesta-
tional length, offspring birth weight, and offspring BMI and
MAP in adolescence.
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We used models progressively adjusting for covariables in
3 steps: model I (offspring age and sex); model II (additionally
adjusted for maternal age at delivery, parity, glycosuria/
diabetes mellitus, smoking during pregnancy, BMI, and
educational level); and model III (additionally adjusted for
birth weight, gestational length, offspring BMI, and MAP at
follow-up). We consider model II to be our main model
because this estimates the direct effect of the exposure on
the outcomes of interest.
Rate of maternal BP change in pregnancy and offspring
cardiac structure and function
To model associations with maternal gestational SBP and DBP
change, we constructed BP trajectories using multilevel spline
models (measurement occasion by woman) as previously
described.19,20 First, offspring whose mothers had less than 2
BP measurements following the 20th week of gestation were
excluded (N=81). To analyze the maternal BP change during
different stages of pregnancy, we modeled DBP and SBP
change (each separately) during 4 periods from week 8
onward (gestational weeks 8–18, 18–30, 30–36, and ≥36),
each knot point demarcating periods of linear rate of change
in BP. To relate maternal BP change to offspring cardiac
outcomes, we formed a bivariate model by extending the
multilevel models for BP change to include the offspring
outcome as an extra response variable at the woman level
(level 2). Regression coefﬁcients for the associations of BP at
baseline and rates of BP change in each period with the
outcomes were derived from the level 2 variance–covariance
matrix of the random effects.15,21 Here, too, we used
progressively adjusted models: model I (offspring age and
sex); model II (additionally adjusted for maternal age at
delivery, parity, glycosuria/diabetes mellitus, smoking during
pregnancy, maternal BMI, maternal educational level, mater-
nal SBP [or DBP] gestational week 8 [baseline], and, when
applicable, previous SBP [or DBP] change during pregnancy);
model III (additionally adjusted for hypertension during
pregnancy); and model IV (additionally adjusted for offspring
birth weight, gestational length, offspring BMI at follow-up,
and offspring MAP at follow-up). Potential confounders that
could affect the maternal BP trajectory (offspring sex [model
I], maternal age at birth, parity, glycosuria/diabetes mellitus,
smoking during pregnancy, maternal BMI, maternal educa-
tional level [model II], and maternal hypertension during
pregnancy [model III]) were adjusted for by including these in
the maternal BP part of the multilevel model. More speciﬁ-
cally, these variables were included as main effects and as
interactions with each spline to fully adjust for their associ-
ation with the whole trajectory of maternal BP change. At
each stage of adjustment, all confounders and mediators to
be adjusted for at that particular stage were also included as
covariates in the offspring outcome part of the multilevel
model.
Results
In models of maternal hypertension in pregnancy, 1592
offspring were included whereas 1511 offspring were included
in models of BP trajectories (Figure 1). In total, 2.6% of
offspring had been exposed to maternal preeclampsia. Table
shows the study sample characteristics and Table S1 shows
the characteristics in our study sample compared to those
who attended the year 17 assessment clinic and to the entire
ALSPAC offspring cohort. Offspring examined with echocar-
diography appeared similar to all offspring who attended the
year 17 clinic assessment, including BMI, SBP, and DBP.
Mothers of all offspring who attended the year 17 clinic
tended to have been somewhat older at delivery, more likely
to have had a girl than boy, more likely to have had no
previous pregnancies, more likely not to smoke throughout
pregnancy, and to have a higher level of education compared
to the ALSPAC cohort overall.
Associations between maternal preeclampsia, gestational
hypertension, and essential hypertension and offspring cardiac
structure and function from our main confounder adjusted
model (model II) are summarized in Figure 2 (Table S2 shows
results from all models). Mean RWT was greater in offspring
exposed to a hypertensive disorder during pregnancy, whereas
only offspring exposed to maternal preeclampsia had smaller
mean LVED volume. We observed similar results in a sensitivity
analyses using LVED volume indexed to height in m2.7 (data not
shown). Maternal preeclampsia and essential hypertension
were associated with greater offspring RWT in all 3 models.
Gestational hypertension was also associated with greater RWT
in model II. Gestational hypertension and essential hyperten-
sion were positively associated with LVMI in model I, but the
association persisted only for essential hypertension after
further adjustment for maternal and offspring factors. We found
no association between hypertension in pregnancy and
offspring cardiac function.
Figure 3 shows associations between rate of maternal SBP
change across pregnancy with measures of offspring cardiac
structure and function from model II (main confounder
adjusted model). Rate of maternal SBP change during weeks
8 to 18 was positively associated with offspring LVMI, LVED
volume, and E/A (ie, a shallower decrease in maternal SBP
was associated with offspring outcomes). Full results from all
models are presented in Table S3.
Rate of maternal DBP change during weeks 8 to 18 was
positively associated with E/e0 (Figure 4). No other associa-
tion was found between rate of maternal DBP change during
pregnancy and offspring cardiac outcomes (Table S4).
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Discussion
In this cohort study, we found offspring exposed to maternal
preeclampsia to have a distinct cardiac structure approaching
concentric remodeling. Compared to offspring of normotensive
women, they had greater mean RWT and lower mean LVED
volume, but no difference in LVMI. Offspring exposed to
maternal gestational hypertension had increased RWT without
any concomitant decrease in LVED volume, and we observed
similar results in offspring of mothers with essential hyperten-
sion in our main model. However, we found no associations
between maternal preeclampsia and offspring cardiac function
and no consistent association between rate of maternal BP
Table. Description of Study Participants by Maternal Hypertensive Status During Pregnancy
Normotensive Preeclampsia
Gestational
Hypertension
Essential
Hypertension
P Value for
Difference
No. of participants (%) 1260 (79.1) 42 (2.6) 247 (15.5) 43 (2.7) n/a
Female offspring (%) 697 (55.3) 20 (47.6) 121 (49.0) 19 (44.2) 0.13
Birth weight, kg, mean (SD) 3.44 (0.49) 3.00 (0.80) 3.46 (0.56) 3.34 (0.53) <0.001
Maternal age at delivery, y, mean (SD) 29.5 (4.5) 30.0 (5.4) 29.2 (4.8) 29.3 (4.7) 0.65
Gestational age at birth, weeks, median (IQR) 40 (39–41) 38.5 (36–40) 40 (39–41) 39 (38–40) <0.001
Maternal prepregnancy BMI, kg/m2, median (IQR) 21.8 (20.4–23.8) 24.1 (21.1–27.5) 23.3 (21.5–26.5) 23.6 (21.8–27.8) <0.001
First pregnancy (%) 607 (48.2) 30 (71.4) 147 (59.5) 29 (67.4) <0.001
Diabetes mellitus or glycosuria during pregnancy (%) 36 (2.9) 6 (14.3) 10 (4.0) 2 (4.7) <0.001
Maternal smoking status during pregnancy (%) 0.03
Never smoked 998 (79.2) 33 (78.6) 210 (85.0) 34 (79.1)
Stopped before the second trimester 100 (7.9) 7 (16.7) 21 (8.5) 3 (7.0)
Smoked during the second trimester 162 (12.9) 2 (4.8) 16 (6.5) 6 (14.0)
Maternal educational level (%) 0.02
Compulsory/vocational 238 (18.9) 10 (23.8) 39 (15.8) 4 (9.3)
Compulsory (higher achievement) 405 (32.1) 13 (31.0) 100 (40.5) 23 (53.5)
Secondary (academic preparation) 351 (27.9) 14 (33.3) 54 (21.9) 8 (18.6)
Tertiary/degree 266 (21.1) 5 (11.9) 54 (21.9) 8 (18.6)
Measures from the 17 years follow-up clinic
Offspring age, y, mean 17.7 (0.3) 17.7 (0.3) 17.7 (0.3) 17.6 (0.3) 0.35
Offspring BMI, kg/m2, median (IQR) 21.7 (19.9–24.4) 22.7 (19.9–24.8) 22.8 (20.7–25.7) 22.4 (19.4–24.7) <0.001
Offspring MAP, mm Hg, mean (SD) 81.5 (6.7) 84.4 (6.2) 83.6 (7.0) 83.3 (6.7) <0.001
Cardiac structure
Relative wall thickness, mean (SD), N=1591 0.37 (0.05) 0.40 (0.06) 0.38 (0.6) 0.39 (0.07) 0.008
LVMI, g/m2.7, mean (SD) 29 (6) 29 (7) 30 (7) 31 (7) 0.003
LVED volume, mL, mean (SD) 94 (21) 89 (21) 97 (23) 97 (21) 0.06
Systolic function
Ejection fraction, %, mean (SD) 67 (6) 68 (5) 67 (6) 68 (5) 0.19
Midwall fractional shortening, %, mean (SD), N=1591 16 (2) 16 (2) 16 (2) 16 (2) 0.97
Average s0, cm/s, mean (SD), N=1522 7.8 (1.5) 8.3 (1.7) 7.9 (1.4) 7.5 (1.2) 0.11
Diastolic function
Mitral E/A ratio, mean (SD), N=1533 1.9 (0.4) 1.9 (0.5) 1.9 (0.4) 2.0 (0.4) 0.19
Lateral E/e0 ratio mean (SD), N=1520 4.9 (1.0) 4.8 (0.9) 4.8 (1.0) 5.0 (1.2) 0.67
LADI, cm/m2.7, mean (SD), N=1426 0.75 (0.12) 0.77 (0.13) 0.75 (0.13) 0.74 (0.14) 0.78
BMI indicates body mass index; IQR, interquartile range; LADI, left atrial diameter indexed to height in m2.7; LVED volume, left ventricular end-diastolic volume; LVMI, left ventricular mass
indexed to height in m2.7; MAP, mean arterial pressure; n/a, not applicable.
DOI: 10.1161/JAHA.116.003906 Journal of the American Heart Association 5
Preeclampsia and Offspring Cardiac Structure Timpka et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on N
ovem
ber 25, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
change throughout pregnancy and offspring cardiac outcomes.
The few associations between maternal BP changes and
offspring cardiac outcomes that we did observe, and which
were not attenuated when adjusted for potential confounders
or mediators, appertained to early pregnancy. More speciﬁ-
cally, we found maternal SBP change during gestational weeks
8 to 18 to be associated with offspring cardiac mass (LVMI),
LVED volume, and a measure of diastolic function (E/A).
Several, but not all, studies have suggested that exposure
to maternal preeclampsia or hypertension during pregnancy is
associated with adverse cardiac or vascular structure and
function in offspring in childhood10,22–24 and later in life.25
Fugelseth et al22 found that children exposed to preeclampsia
(N=25) have smaller hearts compared to nonexposed at age 5
to 8 years, but the reference group included a large
proportion of diabetic pregnancies. Similar to our results,
Himmelmann et al23 observed no difference in left ventricular
mass when comparing offspring born following hypertensive
pregnancies to unexposed offspring (N=52; age, 10–
16 years). In this study, we found no evidence of suboptimal
cardiac function in adolescent offspring exposed to
preeclampsia whereas Lewandowski et al25 reported a
decrease in the global longitudinal peak systolic strain in
adult offspring exposed to maternal preeclampsia (N=29).
However, these offspring were born preterm and were also
older (20–39 years) than our sample, which limits compari-
son. Importantly, left ventricular concentric remodeling is
associated with increased risk of coronary heart disease and
stroke in middle-aged and older adults.26 Given that concen-
tric remodeling increases with age,27 the suboptimal cardiac
structure we observed in offspring exposed to maternal
preeclampsia might further worsen with age and exposure to
additional CVD risk factors across the life course.
Women with preeclampsia have altered left ventricular
geometry compared to those with a normal pregnancy,28 which
only partly is reversible postpartum.29 Likewise, women with
gestational hypertension have higher RWT, a measure of left
ventricular concentricity, in late pregnancy compared to
normotensive pregnant women,30 and RWT in adolescence
seems to have a substantial heritable component (30%).31
Thus, women with altered cardiac geometry or greater RWT
might be bothmore likely to have preeclampsia or hypertension
during pregnancy, as well as to have offspring with altered
cardiac geometry and higher RWT simply because of shared
genes between mother and offspring. An alternative explana-
tion is that exposure to maternal hypertension in utero, or the
Figure 2. Mean difference (95% CI) in adolescent echocardiography measures between offspring exposed
to preeclampsia, gestational hypertension, and essential hypertension in utero compared to offspring of
normotensive women. Results obtained from the main model (model II). EF indicates ejection fraction; EH,
essential hypertension; GH, gestational hypertension; LADI, left atrial diameter indexed to height in m2.7;
LVEDv, left ventricular end diastolic volume; LVMI, left ventricular mass indexed to height in m2.7; MFS, left
ventricular midwall fractional shortening; PE, preeclampsia; RWT, relative wall thickness.
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processes causing the hypertension, has a direct effect on
offspring cardiac development resulting in altered structure in
adolescence.
High resistance in the umbilical artery has been shown to
be associated with low cardiac mass in preschool offspring,32
suggesting an association between the hemodynamics in
utero and later cardiac structure and function. Furthermore,
Kuznetsova et al reported that offspring measures of cardiac
structure, such as left ventricular mass, have a higher
correlation with maternal than paternal measurements,33
lending some support for a direct maternal-speciﬁc effect.
Higher BP is a risk factor for cardiac remodeling and
preeclampsia is a risk factor for small birth size,34 which is
associated with more-adverse cardiovascular development in
the offspring.35 When accounting for offspring factors (birth
weight, gestational length, BMI, and MAP) in model III, the
association between exposure to maternal preeclampsia or
essential hypertension and later RWT remained, but was
abolished for maternal gestational hypertension. The associ-
ation between maternal preeclampsia and offspring LVED
volume was similar in models II and III. Thus, the association
between maternal preeclampsia and offspring cardiac struc-
ture measures seems to be independent of offspring’s own BP
or birth size. That said, this approach assumes no measure-
ment error in the mediators and this cannot be ruled out. We
found that women with smaller decreases in SBP in weeks 8
to 18 had offspring with larger LVMI, LVED volume, and less
optimal diastolic function. A previous study on mothers in the
ALSPAC cohort also showed that those with gestational
hypertension had a smaller decrease in BP than normotensive
mothers during gestational weeks 8 to 18 (Figure S1).19 Early
pregnancy is a sensitive period for fetal cardiac development,
and it is possible that maternal BP, or other cardiovascular
adaptions to pregnancy, has a direct effect on the develop-
ment of offspring cardiac structures. Cardiac structures
develop early in the human fetus, and by the end of the ﬁrst
trimester they are largely developed and functional.36 The
implications of these associations for offspring cardiac
development are not yet known.
The main strengths of this study are the prospective cohort
design, the available data on multiple possible confounders
and mediators, and the number of repeated measures of
maternal BP during pregnancy. The study data were mostly
collected as part of routine antenatal care in the UK, a
structured and low-threshold health care setting. Maternal BP
and the concomitant urine dipstick measurements were
Figure 3. Mean difference (95% CI) in adolescent offspring echocardiography measures per mm Hg/
week rate of maternal systolic blood pressure change during pregnancy. Results obtained from the main
model (model II). EF indicates ejection fraction; EH, essential hypertension; MFS, left ventricular midwall
fractional shortening; LADI, left atrial diameter indexed to height in m2.7; LVEDv, left ventricular end-
diastolic volume; LVMI, left ventricular mass indexed to height in m2.7; RWT, relative wall thickness.
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collected as part of routine maternity visits, though there was
little standardization in terms of the frequency of visits or the
time of day. However, few cases should have been missed in
the sample, and the use of routine measurements meant that
we were able to apply standard deﬁnitions of preeclampsia
and gestational hypertension to all women rather than relying
on recorded diagnoses. The study has some potential
limitations: Late adolescence might be too early to detect
changes in cardiac function that progress with age. The study
sample might have differed somewhat from the total ALSPAC
cohort, with offspring of older and more-educated women
being more likely to remain engaged with the study. That said,
we cannot think of a plausible reason why this would induce
major bias in the association between preeclampsia and the
echocardiography outcomes. Despite the large sample size,
the number of participants exposed to preeclampsia was
limited. Another limitation is that we do not have data on any
medical action taken based on a maternal diagnosis of
preeclampsia or hypertension. Finally, we conducted multiple
tests, and though these were not all independent of one
another, it is possible that some reported associations could
be attributed to chance. Therefore, focus should be on the
pattern of reported observations, and caution is required in
the interpretation of speciﬁc associations until these are
further replicated.
Conclusion
Adolescent offspring exposed in utero to maternal
preeclampsia had evidence of early unfavorable changes in
cardiac structure with increased mean RWT and reduced
LVED volume (ie, a concentric type of remodeling). Offspring
exposed to gestational hypertension had higher mean RWT
only. Our results support the hypothesis that fetal exposure
to preeclampsia is associated with a more-adverse cardiac
structure in youth. The long-term implications of these ﬁnd-
ings for cardiovascular health remain to be established,
and further replication of speciﬁc associations is warranted.
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Table S1. Description of study sample   
Obstetric and maternal variables Study sample Total follow-up, age 17 year 
clinic 
ALSPAC offspring alive > 
age 1 years 
Number of subjects (singletons with birth data) 1,592 4,770 13,617 
Female offspring, N (%) 857 (53.8)   2,676 (56.1)  6,594 (48.4) 
Birth weight, kg Mean (SD) 3.43 (0.51) 3.43 (0.52, N=4,717) 3.41 (0.54, N=13,446) 
Maternal age at delivery, years Mean (SD) 29.5 (4.6) 29.2 (4.7) 28.0 (5.0) 
Gestational length, weeks Median (IQR) 40 (39-41) 40 (39-41) 40 (39-41) 
Maternal pre-pregnancy BMI, Kg/m2 Median (IQR) 22.2 (20.5–24.4) 22.1 (20.5–24.2, N=4,330) 22.9 (20.5-24.7, N=11,255) 
First pregnancy, N (%) 813 (51.1)  2,223 of 4,612 (48.2)  5,660 of 12,600 (44.9)  
Diabetes or glycosuria during pregnancy, N (%) 54 (3.4)  189 of 4,583 (4.1)  494 of 12,047 (4.1)  
HDP or hypertension, N (%)  N=4,546 N=13,845 
- No HDP or hypertension 1,260 (79.2)  3,613 (79.5)  11,234 (83.8)  
- Gestational hypertension 247 (15.5)  673 (14.8)  1,886 (14.4)  
- Preeclampsia 42 (2.6)  107 (2.4)  281 (2.1)  
- Essential hypertension 43 (2.7)  153 (3.4)  444 (3.2)  
Maternal smoking status during pregnancy, N (%)  N=4,674 N=12,777 
- Never smoked  1,275 (80.1)  3,595 (76.9)  9,520 (74.5)  
- Stopped prior the second trimester 131 (8.2)  486 (10.4)  885 (6.9)  
- Smoked during the second trimester 186 (11.7)  593 (12.7)  2,372 (18.6)  
Maternal educational level, N (%)  N=4,604 N=12,102 
- Compulsory/Vocational 291 (18.3)  896 (19.5)  2,439 (20.2)  
- Compulsory (higher achievement) 541 (34.0)  1,571 (34.1)  1,196 (30.0)  
- Secondary (academic preparation) 427 (26.8)  1,277 (27.7)  4,185 (34.6)  
- Tertiary/Degree 333 (20.9)  860 (18.7)  1,554 (12.8)  
Measures from the 17 years follow-up clinic    
Offspring age, Mean years (SD) 17.7 (0.3) 17.8 (0.4) n/a 
Offspring BMI, Kg/m2 Median (IQR) 21.8 (20.0-24.6) 21.9 (20.1-24.6, N=4,632) n/a 
Offspring SBP, mmHg Mean (SD) 118.9 (11.0) 118.5 (10.9, N=4,297) n/a 
Offspring DBP, mmHg Mean (SD) 63.5 (6.5) 63.9 (6.6, N=4,297) n/a 
Offspring MAP, mmHg Mean (SD) 82.0 (6.8) 82.1 (6.8, N=4,297) n/a  
ALSPAC: the Avon Longitudinal Study of Parents and Children, BMI: Body mass index, DBP: Diastolic blood pressure, HDP: Hypertension disorders 
of pregnancy, IQR: Interquartile range, MAP: Mean arterial pressure, SBP: Systolic blood pressure, SD: Standard deviation 
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Table S2. The association between preeclampsia or hypertension during pregnancy and adolescent offspring cardiac structure and function shown 
as mean differences compared to offspring of normotensive women. 
Outcome Model Preeclampsia Gestational hypertension Essential hypertension 
  Mean 95 % CI Mean 95 % CI Mean 95 % CI 
Cardiac structure           
RWT I* 0.021 0.004 0.038 0.007 -0.0005 0.015 0.017 0.001 0.034 
 II† 0.025 0.008 0.043 0.010 0.002 0.017 0.021 0.004 0.038 
 III‡ 0.021 0.004 0.039 0.007 -0.0003 0.015 0.019 0.002 0.036 
LVMI, g/m2.7 I 0.001 -1.9 1.9 1.2 0.33 2.0 2.2 0.31 4.0 
 II -0.63 -2.5 1.3 0.66 -0.19 1.5 1.6 -0.27 3.4 
 III -0.52 -2.2 1.1 0.15 -0.57 0.88 1.8 0.19 3.4 
LVEDv, ml I -6.7 -13 -0.8 1.7 -0.9 4.3 0.9 -4.9 6.6 
 II -9.0 -15 -3.1 0.1 -2.6 2.7 -1.3 -7.0 4.5 
 III -6.7 -12 -1.1 -0.6 -3.1 1.9 -0.4 -5.9 5.1 
Systolic function           
EF, % I 1.6 -0.34 3.5 0.81 -0.04 1.7 1.2 -0.66 3.1 
 II 1.2 -0.77 3.1 0.66 -0.21 1.5 1.1 -0.77 3.1 
 III 1.0 -1.0 3.0 0.64 -0.24 1.5 1.1 -0.84 3.0 
MFS, % I -0.10 -0.75 0.56 0.05 -0.24 0.34 -0.01 -0.65 0.63 
 II -0.30 -0.96 0.36 -0.04 -0.34 0.25 -0.11 -0.76 0.54 
 III -0.26 -0.93 0.42 0.0003 -0.30 0.30 -0.09 -0.74 0.56 
s' I 0.43 -0.03 0.89 0.05 -0.16 0.25 -0.27 -0.71 0.18 
 II 0.35 -0.12 0.82 -0.01 -0.22 0.20 -0.33 -0.78 0.11 
 III 0.30 -0.18 0.77 -0.01 -0.22 0.20 -0.36 -0.81 0.09 
Diastolic function           
E/A I -0.01 -0.13 0.12 -0.05 -0.11 0.003 0.07 -0.06 0.19 
 II 0.01 -0.12 0.14 -0.05 -0.10 0.010 0.07 -0.05 0.20 
 III 0.02 -0.11 0.15 -0.04 -0.09 0.020 0.08 -0.04 0.20 
E/e' I -0.042 -0.36 0.28 -0.052 -0.19 0.09 0.10 -0.20 0.41 
 II 0.004 -0.32 0.33 -0.035 -0.18 0.11 0.13 -0.18 0.44 
 III -0.003 -0.33 0.33 -0.021 -0.16 0.12 0.13 -0.18 0.43 
LADI, cm/m2.7 I 0.024 -0.014 0.062 0.005 -0.011 0.022 0.006 -0.032 0.043 
 II 0.013 -0.025 0.052 -0.001 -0.018 0.016 -0.003 -0.040 0.035 
 III 0.011 -0.025 0.046 -0.008 -0.023 0.008 0.004 -0.031 0.038 
95 % CI: 95 % confidence interval,  A: Velocity of the late filling wave of the left ventricle in diastole, e’: Tissue velocity of the lateral mitral annulus 
during early diastolic filling of the left ventricle, E: Velocity of early filling wave of the left ventricle in diastole, EF: Ejection Fraction, EH: Essential 
hypertension, MFS: Midwall fractional shortening, LADI: Left atrial diameter indexed to height in m2.7, LVEDv: Left ventricular end diastolic volume, 
LVMI: Left ventricular mass indexed to height in m2.7, RWT: Relative wall thickness, s’: Average tissue velocity of the septal and lateral left 
ventricular wall in systole 
* Model I adjusted for offspring sex, offspring age at follow-up 
† Model II additionally adjusted for maternal age, diabetes/glycosuria during pregnancy, parity, smoking during pregnancy, maternal body mass 
index, maternal education 
‡ Model III additionally adjusted for offspring birth weight, gestational length, offspring body mass index, offspring mean arterial pressure 
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Table S3. The association between rate of maternal systolic blood pressure change during pregnancy and offspring cardiac outcomes in adolescence 
Outcome Model Rate of blood pressure change during gestation (mmHg/week) 
  Week 8-18 Week 18-30 Week 30-36 ≥ Week 36 
  Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI 
Cardiac structure             
RWT I* -0.005 -0.020 0.007 0.003 -0.019 0.028 0.005 -0.002 0.012 -0.001 -0.009 0.006 
 II† -0.001 -0.016 0.012 0.004 -0.023 0.042 0.006 -0.004 0.016 -0.001 -0.015 0.011 
 III‡ -0.003 -0.017 0.010 0.003 -0.026 0.044 0.004 -0.008 0.015 -0.001 -0.017 0.013 
LVMI, I 1.4 0.14 3.5 -1.7 -5.2 0.6 0.19 -0.5 1.0 -0.53 -1.5 0.2 
g/m2.7 II 1.5 0.17 3.5 -1.3 -7.3 1.3 0.37 -0.6 2.2 -0.73 -3.8 0.8 
 III 1.1 0.03 2.9 -1.5 -7.7 0.9 -0.05 -1.1 1.8 -0.82 -4.1 0.9 
LVEDv, I 4.9 0.89 11 -4.5 -15 2.6 -0.52 -2.9 1.8 -0.6 -3.2 1.8 
ml II 4.2 0.27 10 -3.1 -20 5.0 -0.25 -3.2 4.5 -1.1 -7.7 3.0 
 III 3.6 -0.10 9.3 -3.5 -22 4.5 0.25 -3.2 5.9 -1.7 -11 3.2 
Systolic function             
EF, % I 0.02 -1.5 1.6 0.29 -2.3 3.1 0.19 -0.56 1.0 -0.20 -1.1 0.55 
 II -0.01 -1.6 1.5 0.70 -2.4 4.9 0.18 -0.96 1.3 -0.36 -2.1 0.87 
 III -0.07 -1.6 1.5 0.53 -2.9 4.9 -0.03 -1.4 1.2 -0.48 -2.6 0.97 
MFS, % I 0.15 -0.34 0.70 0.04 -0.9 1.0 -0.06 -0.33 0.19 -0.04 -0.33 0.22 
 II 0.02 -0.48 0.57 0.14 -1.0 1.4 -0.08 -0.47 0.28 -0.10 -0.62 0.32 
 III 0.05 -0.44 0.60 0.13 -1.2 1.4 -0.09 -0.56 0.34 -0.13 -0.81 0.36 
s' I -0.26 -0.73 0.08 0.47 -0.11 1.5 0.0002 -0.18 0.19 -0.004 -0.18 0.17 
 II -0.28 -0.75 0.05 0.54 -0.20 2.9 -0.038 -0.78 0.27 0.015 -0.58 0.69 
 III -0.30 -0.77 0.03 0.58 -0.24 3.6 -0.053 -1.0 0.38 0.030 -0.69 1.0 
Diastolic function             
E/A I 0.11 0.02 0.26 -0.16 -0.43 -0.01 -0.003 -0.05 0.05 -0.02 -0.07 0.02 
 II 0.11 0.02 0.26 -0.19 -0.94 0.01 -0.002 -0.10 0.23 -0.03 -0.23 0.16 
 III 0.13 0.04 0.28 -0.18 -1.1 0.03 -0.007 -0.14 0.25 -0.03 -0.27 0.19 
E/e' I 0.11 -0.12 0.40 -0.22 -0.75 0.17 -0.072 -0.20 0.05 0.11 0.01 0.25 
 II 0.13 -0.10 0.41 -0.25 -1.2 0.22 -0.076 -0.27 0.19 0.10 -0.11 0.39 
 III 0.13 -0.10 0.41 -0.22 -1.3 0.30 -0.12 -0.36 0.18 0.11 -0.13 0.46 
LADI, I 0.023 -0.003 0.059 -0.02 -0.08 0.02 0.0003 -0.015 0.015 -0.012 -0.029 -0.0004 
cm/m2.7 II 0.022 -0.003 0.059 -0.02 -0.10 0.03 0.0029 -0.015 0.031 -0.014 -0.045 0.0032 
 III 0.022 -0.0003 0.058 -0.01 -0.10 0.04 -0.010 -0.035 0.015 -0.010 -0.038 0.013 
95 % CI: 95 % confidence interval, A: Velocity of the late filling wave of the left ventricle in diastole, e’: Tissue velocity of the lateral mitral annulus during early 
diastolic filling of the left ventricle, E: Velocity of early filling wave of the left ventricle in diastole, EF: Ejection Fraction. EH: Essential hypertension, MFS: Midwall 
fractional shortening, LADI: Left atrial diameter indexed to height in m2.7, LVEDv: Left ventricular end diastolic volume, LVMI: Left ventricular mass indexed to 
height in m2.7, RWT: Relative wall thickness, s’: Average tissue velocity of the septal and lateral left ventricular wall in systole 
* Model I adjusted for offspring sex, offspring age at follow-up 
† Model II additionally adjusted for maternal age, diabetes/glycosuria during pregnancy, parity, smoking during pregnancy, maternal body mass index, maternal 
education, maternal systolic blood pressure gestational week 8, and, when applicable, previous rate of blood pressure change during the pregnancy 
‡ Model III additionally adjusted for maternal preeclampsia/hypertension during pregnancy, offspring birth weight, gestational length, offspring body mass index, 
offspring mean arterial pressure 
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Table S4. The association between rate of maternal diastolic blood pressure change during pregnancy and offspring cardiac outcomes in adolescence 
Outcome Model Rate of blood pressure change during gestation (mmHg/week) 
Week 8-18 Week 18-30 Week 30-36 ≥  Week 36 
Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI 
Cardiac structure 
RWT I* 0.010 -0.013 0.043 -0.011 -0.042 0.014 0.004 -0.001 0.010 0.002 -0.002 0.006
II† 0.016 -0.010 0.054 -0.008 -0.057 0.020 0.004 -0.003 0.011 0.005 -0.008 0.026
III‡ 0.012 -0.015 0.050 -0.014 -0.074 0.017 0.001 -0.008 0.009 0.004 -0.019 0.031
LVMI, I 1.9 -0.5 6.4 -1.4 -4.9 1.3 0.17 -0.43 0.79 -0.08 -0.5 0.4
g/m2.7 II 2.0 -0.6 6.7 -0.8 -6.9 2.3 -0.05 -0.89 0.72 0.15 -1.2 2.3
III 0.7 -1.9 4.0 -0.6 -5.0 2.6 -0.18 -0.94 0.49 -0.36 -2.2 1.4
LVEDv, I 3.8 -3.8 15 -0.7 -10 8.3 -0.85 -2.8 1.0 -0.45 -1.9 1.0
ml II 3.2 -5.3 16 0.7 -13 11 -1.3 -3.7 0.9 -0.29 -4.1 4.7
III 0.7 -9.0 11 2.7 -8.9 16 -0.44 -2.8 1.9 -1.3 -8.8 4.8
Systolic function 
EF, % I 0.24 -2.5 3.4 -0.05 -3.2 3.0 0.33 -0.28 0.97 -0.16 -0.6 0.3
II 0.31 -2.9 3.8 0.15 -3.7 4.0 0.32 -0.39 1.0 -0.22 -1.7 1.1
III 0.34 -2.9 4.3 -0.33 -5.3 3.7 0.16 -0.70 0.99 -0.50 -2.9 1.7
MFS, % I -0.15 -1.2 0.8 0.20 -0.8 1.3 0.004 -0.20 0.22 -0.09 -0.25 0.07
II -0.27 -1.5 0.8 0.20 -1.0 1.8 0.012 -0.23 0.26 -0.17 -0.86 0.29
III -0.16 -1.4 1.0 0.19 -1.2 1.8 0.030 -0.25 0.32 -0.21 -1.2 0.51
s' I -0.21 -1.0 0.37 0.047 -0.65 0.76 0.13 -0.006 0.29 -0.037 -0.14 0.07
II -0.21 -1.1 0.41 0.001 -0.74 0.97 0.14 -0.024 0.31 -0.064 -0.42 0.12
III -0.20 -1.1 0.42 0.025 -0.78 1.1 0.15 -0.034 0.36 -0.060 -0.59 0.24
Diastolic function 
E/A I 0.007 -0.16 0.19 0.068 -0.14 0.32 -0.010 -0.052 0.031 0.03 -0.06 0.001
II -0.016 -0.21 0.18 0.052 -0.20 0.37 -0.004 -0.051 0.044 -0.04 -0.14 0.02
III -0.003 -0.20 0.21 0.062 -0.22 0.42 -0.002 -0.055 0.051 -0.05 -0.18 0.05
E/e' I 0.43 0.05 1.3 -0.41 -1.1 0.04 0.023 -0.08 0.13 -0.01 -0.09 0.06
II 0.42 0.01 1.2 -0.35 -1.7 0.18 0.005 -0.14 0.17 0.04 -0.14 0.48
III 0.46 0.05 1.4 -0.43 -2.3 0.15 -0.019 -0.23 0.16 0.05 -0.43 0.68
LADI, I 0.015 -0.031 0.078 0.01 -0.04 0.07 -0.003 -0.015 0.010 -0.005 -0.014 0.003
cm/m2.7 II 0.009 -0.045 0.077 0.03 -0.03 0.09 -0.002 -0.016 0.012 -0.005 -0.030 0.017
III -0.003 -0.060 0.054 0.04 -0.02 0.12 -0.008 -0.024 0.007 -0.009 -0.057 0.023
95 % CI: 95 % confidence interval, A: Velocity of the late filling wave of the left ventricle in diastole, e’: Tissue velocity of the lateral mitral annulus during early diastolic filling of 
the left ventricle, E: Velocity of early filling wave of the left ventricle in diastole, EF: Ejection Fraction. EH: Essential hypertension, MFS: Midwall fractional shortening, LADI: Left 
atrial diameter indexed to height in m2.7, LVEDv: Left ventricular end diastolic volume, LVMI: Left ventricular mass indexed to height in m2.7, RWT: Relative wall thickness, s’: 
Average tissue velocity of the septal and lateral left ventricular wall in systole 
* Model I adjusted for offspring sex, offspring age at follow-up 
† Model II additionally adjusted for maternal age, diabetes/glycosuria  during pregnancy, parity, smoking during pregnancy, maternal body mass index, maternal education, 
maternal diastolic blood pressure gestational week 8, and, when applicable, previous rate of blood pressure change during the pregnancy 
‡ Model III additionally adjusted for maternal preeclampsia/hypertension during pregnancy, offspring birth weight, gestational length, offspring body mass index, offspring mean 
arterial pressure 
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Figure Legend: 
Figure S1. Description of the maternal blood pressure trajectories during pregnancy by 
hypertensive disorders of pregnancy in the ALSPAC cohort. Reproduced with permission 
from Hypertension1 
Figure S1. 
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